New Migraine Drugs, Erenumab and Fremanezumab, Show Promise

WEDNESDAY, Nov. 29, 2017 — Two new migraine drugs have shown promise in late-stage clinical trials.
The drugs were designed specifically to target a pathway believed to be important in these headaches.
In stage 3 clinical trials, the drugs were…
Source: Topamax